{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-024494","form_type":"8-K","ticker":"NVNO","cik":"0001661053","company_name":"enVVeno Medical Corp","filed_at":"2025-11-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.069003+00:00","generated_at":"2026-05-16T18:01:22.313506+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"enVVeno Medical lowers stockholder meeting quorum to 33-1/3% voting power","bullets":["Board approved amendment to Section 1.5 of Amended and Restated Bylaws on November 17, 2025.","New quorum threshold: presence of holders of 33⅓% of voting power of outstanding shares entitled to vote.","Amendment effective immediately upon Board approval; no stockholder vote required.","Change modifies quorum requirement from the prior standard (not specified) to one-third threshold."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-024494","json":"https://secwatch.observer/filing/0001493152-25-024494.json","markdown":"https://secwatch.observer/filing/0001493152-25-024494.md","text":"https://secwatch.observer/filing/0001493152-25-024494.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225024494/0001493152-25-024494-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225024494/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:01:22.313506+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c222e029a6f48c872d992d50d808c66236a404b5","claim":"enVVeno Medical Corp: Amended Section 1.5 of the bylaws to reduce the quorum requirement for stockholder meetings from a majority to 33.33% of voting power (effective 2025-11-17).","evidence_excerpt":"On November 17, 2025, the Board of Directors of enVVeno Medical Corporation (“we,” “us,” “our,” or the “Company”) approved an amendment to the Company’s Amended and Restated Bylaws. The amendment revises Section 1.5 to modify the quorum requirement for meetings of stockholders. As amended, Section 1.5 provides that, except as otherwise required by applicable law, the certificate of incorporation or the bylaws, the presence in person or by proxy of holders of thirty-three and one-third percent in voting power of the outstanding shares entitled to vote at the meeting shall constitute a quorum.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225024494/0001493152-25-024494-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-11-17"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}